Imbalanced Skeletal Muscle Mitochondrial Proteostasis Causes Bone Loss

Zhen Jin,Yan Mao,Qiqi Guo,Yujing Yin,Abdukahar Kiram,Danxia Zhou,Jing Yang,Zheng Zhou,Jiachen Xue,Zhenhua Feng,Zhen Liu,Yong Qiu,Tingting Fu,Zhenji Gan,Zezhang Zhu
DOI: https://doi.org/10.34133/research.0465
2024-08-30
Abstract:Although microgravity has been implicated in osteoporosis, the precise molecular mechanism remains elusive. Here, we found that microgravity might induce mitochondrial protein buildup in skeletal muscle, alongside reduced levels of LONP1 protein. We revealed that disruptions in mitochondrial proteolysis, induced by the targeted skeletal muscle-specific deletion of the essential mitochondrial protease LONP1 or by the acute inducible deletion of muscle LONP1 in adult mice, cause reduced bone mass and compromised mechanical function. Moreover, the bone loss and weakness phenotypes were recapitulated in skeletal muscle-specific overexpressing ΔOTC mice, a known protein degraded by LONP1. Mechanistically, mitochondrial proteostasis imbalance triggered the mitochondrial unfolded protein response (UPRmt) in muscle, leading to an up-regulation of multiple myokines, including FGF21, which acts as a pro-osteoclastogenic factor. Surprisingly, this mitochondrial proteostasis stress influenced muscle-bone crosstalk independently of ATF4 in skeletal muscle. Furthermore, we established a marked association between serum FGF21 levels and bone health in humans. These findings emphasize the pivotal role of skeletal muscle mitochondrial proteostasis in responding to alterations in loading conditions and in coordinating UPRmt to modulate bone metabolism.
What problem does this paper attempt to address?